# Alexandria Real Estate Equities: portfolio, investments and team

> Alexandria Real Estate Equities is a vc firm based in United States. 107 investments on record, 2 in the last 12 months, latest Jun 2026.

Source: https://millionrounds.com/fund/alexandria (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Alexandria Real Estate Equities

Last cheque observed Jun 2026; 107 cheques on record.

Email

Deploying now VC firm

Seed Series A Series B Mental Health Well-being Healthtech

Follow Alexandria Real Estate Equities and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Falexandria)

Deploying now

**67%** of best year **2** **cheques in 12 months**, 107 on record

Since the last cheque **142** days **00** hrs **00** min **00** sec

Median round **$45M** Rounds led **1 of 107** Sole investor **1 rounds** Exits **1 from the portfolio** Mostly in **United States, 93%**

Pitch Alexandria Real Estate Equities

## Alexandria Real Estate Equities highlights

- 01 2 cheques in the last 12 months
- 02 Mostly Series B and Series A: 81% of its rounds
- 03 Sole investor in 1 rounds, median $7.0M
- 04 1 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Mental Health Well-being Healthtech
- **Based in:** Pasadena, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **107 appearances**

- **2026** 2 rounds
- **Jun** **[SonoThera](https://millionrounds.com/company/sonothera)** Series B · US · Ventureburn **$125M** With 10 others
- **Apr** **[Sidewinder Therapeutics](https://millionrounds.com/company/sidewinder-therapeutics)** Series B · US · Ventureburn **$137M** With 8 others
- **2025** 2 rounds
- **May** **[HAYA Therapeutics](https://millionrounds.com/company/haya-therapeutics)** Series A · CH · Firms' own news pages **$65M** With 11 others
- **Feb** **[Eikon Therapeutics](https://millionrounds.com/company/eikon-therapeutics)** Series D · US · Crunchbase News **$351M** With 4 others
- **2024** 2 rounds
- **Oct** **[March Biosciences](https://millionrounds.com/company/march-biosciences)** Series A · US · 4BIO Capital **$28M** With 10 others
- **Mar** **[Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics)** Series B · US · Firms' own news pages **$175M** With 15 others
- **2023** 1 round
- **May** **[Myeloid Therapeutics, Inc.](https://millionrounds.com/company/myeloid-therapeutics-inc)** Series C · US · Hatteras Venture Partners **$73M** With 5 others
- **2021** 2 rounds
- **Sept** **[Kytopen](https://millionrounds.com/company/kytopen)** Series A · US · Firms' own news pages **$30M** With 6 others
- **Jun** **[Veralox Therapeutics](https://millionrounds.com/company/veralox-therapeutics)** Series A · US · Hatteras Venture Partners **$17M** With 8 others
- **2019** 21 rounds
- **Dec** **[Aspen Neuroscience](https://millionrounds.com/company/aspen-neuroscience)** Seed · US · FinSMEs **$6.5M** With 5 others
- **Dec** **[Jasper Therapeutics](https://millionrounds.com/company/jasper-therapeutics)** Series A · US · FinSMEs **$35M** With 3 others
- **Dec** **[ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics)** Series B · FR · FinSMEs **$53M** With 9 others
- **Nov** **[Immunitas](https://millionrounds.com/company/immunitas)** Series A · US · FinSMEs **$39M** With 4 others
- **Oct** **[Adaptive Phage](https://millionrounds.com/company/adaptive-phage)** US · Vcnewsdaily **$7.0M** Sole investor
- **Oct** **[Molecular Assemblies](https://millionrounds.com/company/molecular-assemblies)** Series A · US · FinSMEs **$12M** With 3 others
- **Sept** **[Boundless Bio](https://millionrounds.com/company/boundless-bio)** Series A · US · FinSMEs **$46M** With 5 others
- **Jul** **[X-Vax](https://millionrounds.com/company/x-vax)** Series A · US · FinSMEs **$56M** With 5 others
- **Jul** **[Cradle Genomics](https://millionrounds.com/company/cradle-genomics)** Series A · US · FinSMEs **$17M** With 5 others
- **Jul** **[GNS Healthcare](https://millionrounds.com/company/gns-healthcare)** Series D · US · FinSMEs **$23M** With 5 others
- **Jun** **[Blackthorn Therapeutics](https://millionrounds.com/company/blackthorn-therapeutics)** Series B · US · FinSMEs **$76M** With 11 others
- **Jun** **[Strand Therapeutics](https://millionrounds.com/company/strand-therapeutics)** Seed · US · FinSMEs **$6.0M** With 2 others
- **Apr** **[Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics)** Series B · US · FinSMEs **$75M** With 13 others
- **Mar** **[Prevail Therapeutics](https://millionrounds.com/company/prevail-therapeutics)** Series B · US · Medcitynews **$50M** With 10 others
- **Mar** **[Cardea Bio](https://millionrounds.com/company/cardea-bio)** Series A · US · FinSMEs **$7.8M** *Led*
- **Mar** **[Karuna Therapeutics](https://millionrounds.com/company/karuna-therapeutics)** Series B · US · FinSMEs **$68M** With 8 others
- **Mar** **[Gencove](https://millionrounds.com/company/gencove)** US · FinSMEs **$3.0M** With 4 others
- **Jan** **[Dewpoint Therapeutics](https://millionrounds.com/company/dewpoint-therapeutics)** Series A · US · FinSMEs **$60M** With 4 others
- **Jan** **[GreenLigh Biosciences](https://millionrounds.com/company/greenligh-biosciences)** US · FinSMEs **$50M** With 4 others
- **Jan** **[Frequency Therapeutics](https://millionrounds.com/company/frequency-therapeutics)** Series B · US · FinSMEs **$42M** With 6 others
- **Jan** **[Tiburio Therapeutics](https://millionrounds.com/company/tiburio-therapeutics)** Series A · US · FinSMEs **$31M** With 3 others
- **2018** 23 rounds
- **Dec** **[Kallyope](https://millionrounds.com/company/kallyope)** Series B · US · FinSMEs **$21M** With 6 others
- **Nov** **[Rheostat Therapeutics](https://millionrounds.com/company/rheostat-therapeutics)** Series A · US · FinSMEs **$23M** With 5 others
- **Nov** **[NextCure](https://millionrounds.com/company/nextcure)** Series B · MD · Pehub **$93M** With 12 others
- **Nov** **[Ribometrix](https://millionrounds.com/company/ribometrix)** Series A · US · FinSMEs **$30M** With 10 others
- **Oct** **[Stoke Therapeutics](https://millionrounds.com/company/stoke-therapeutics)** Series B · US · FinSMEs **$90M** With 7 others
- **Oct** **[Rgenix](https://millionrounds.com/company/rgenix)** Series C · US · FinSMEs **$40M** With 4 others
- **Sept** **[KSQ Therapeutics](https://millionrounds.com/company/ksq-therapeutics)** Series C · US · FinSMEs **$80M** With 7 others
- **Sept** **[Silverback Therapeutics](https://millionrounds.com/company/silverback-therapeutics)** Series A · US · GeekWire **$38M** With 1 other
- **Aug** **[Magnolia Neuroscience](https://millionrounds.com/company/magnolia-neuroscience)** Series A · US · FinSMEs **$31M** With 10 others
- **Aug** **[Inari](https://millionrounds.com/company/inari)** Series B · US · FinSMEs **$40M** With 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **17** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **1 in all**

**[GoAhead Software](https://millionrounds.com/company/goahead-software)** Bought by [Oracle Corporation](https://millionrounds.com/fund/oracle) **Undisclosed** Sept 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Seed Series A Series B

Median round joined **$45M** the round, not its cheque Alone, median **$7.0M**

Led 1 of 107 rounds **1%**

- **Sole investor:** 1 rounds
- **Last cheque:** Jun 2026
- **Exits:** 1 from the portfolio

Rounds by stage said on their site

- Series B said *40*
- Series A said *38*
- Series C *9*
- Series D *5*
- Venture *4*
- Seed said *-*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 22
- [Polaris Partners](https://millionrounds.com/fund/polaris-partners) 9
- [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 8
- [Amgen](https://millionrounds.com/fund/amgen) 7
- [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) 7
- [OVP Venture Partners](https://millionrounds.com/fund/ovp-venture-partners) 7

**Pitching Alexandria Real Estate Equities?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Alexandria Real Estate Equities. A count of rooms they were both in, not a relationship either has claimed.

[**ARCH Venture Partners** VC firm **22** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Polaris Partners** VC firm **9** rounds together](https://millionrounds.com/fund/polaris-partners)[**Versant Ventures** VC firm **8** rounds together](https://millionrounds.com/fund/versant-ventures)[**Amgen** Corporate VC **7** rounds together](https://millionrounds.com/fund/amgen)[**EcoR1 Capital** Private equity **7** rounds together](https://millionrounds.com/fund/ecor1-capital)[**OVP Venture Partners** VC firm **7** rounds together](https://millionrounds.com/fund/ovp-venture-partners)[**OrbiMed** Private equity **7** rounds together](https://millionrounds.com/fund/orbimed)[**Pfizer** Corporate VC **7** rounds together](https://millionrounds.com/fund/pfizer)[**Amgen Ventures** Growth equity **6** rounds together](https://millionrounds.com/fund/amgen-ventures)[**Arch** Hedge fund **6** rounds together](https://millionrounds.com/fund/arch)[**Canaan** VC firm **6** rounds together](https://millionrounds.com/fund/canaan-partners)[**Google Ventures** Corporate VC **6** rounds together](https://millionrounds.com/fund/gv)

## Recently backed

The latest companies Alexandria Real Estate Equities put money into.

[**SonoThera** $125M · Jun 2026](https://millionrounds.com/company/sonothera)[**Sidewinder Therapeutics** $137M · Apr 2026](https://millionrounds.com/company/sidewinder-therapeutics)[**HAYA Therapeutics** $65M · May 2025](https://millionrounds.com/company/haya-therapeutics)[**Eikon Therapeutics** $351M · Feb 2025](https://millionrounds.com/company/eikon-therapeutics)[**March Biosciences** $28M · Oct 2024](https://millionrounds.com/company/march-biosciences)[**Kytopen** $30M · Sept 2021](https://millionrounds.com/company/kytopen)

## Quick answers about Alexandria Real Estate Equities

### What does Alexandria Real Estate Equities invest in?

Alexandria Real Estate Equities invests most often at Series B and Series A (81% of the rounds on record), in sectors such as Mental Health, Well-being and Healthtech.

### How active is Alexandria Real Estate Equities?

107 investments on record, 2 of them in the last 12 months, and it led 1. The most recent was in Jun 2026.

### What has Alexandria Real Estate Equities invested in recently?

Its most recent investments on record: SonoThera (Series B, Jun 2026), Sidewinder Therapeutics (Series B, Apr 2026) and HAYA Therapeutics (Series A, May 2025).

### How big are Alexandria Real Estate Equities's cheques?

The median round it joins is $45M.

### Does Alexandria Real Estate Equities lead rounds?

Sometimes: it led 1 of its 107 investments on record (1%).

### Where does Alexandria Real Estate Equities invest?

Most of the companies it backs are in the United States (93%).

### Is Alexandria Real Estate Equities investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

### Who does Alexandria Real Estate Equities invest alongside?

Most often ARCH Venture Partners (22 rounds together), Polaris Partners (9 rounds together) and Versant Ventures (8 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=alexandria) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=alexandria)